Apex Healthcare Bhd (7090) - Total Liabilities

Latest as of September 2025: RM219.04 Million MYR ≈ $54.99 Million USD

Based on the latest financial reports, Apex Healthcare Bhd (7090) has total liabilities worth RM219.04 Million MYR (≈ $54.99 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Apex Healthcare Bhd operating cash flow efficiency to assess how effectively this company generates cash.

Apex Healthcare Bhd - Total Liabilities Trend (2012–2024)

This chart illustrates how Apex Healthcare Bhd's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Apex Healthcare Bhd to evaluate the company's liquid asset resilience ratio.

Apex Healthcare Bhd Competitors by Total Liabilities

The table below lists competitors of Apex Healthcare Bhd ranked by their total liabilities.

Company Country Total Liabilities
Mayville Engineering Co Inc
NYSE:MEC
USA $345.89 Million
TangYuan Electric
SHE:300789
China CN¥382.91 Million
KT Submarine Co. Ltd
KQ:060370
Korea ₩79.71 Billion
Shenzhen Ridge Engineering Consulting Co. Ltd.
SHE:300977
China CN¥188.18 Million
Nanning Department Store Co Ltd
SHG:600712
China CN¥573.52 Million
ValueHD Corp. A
SHE:301318
China CN¥169.99 Million
Diamond Hill Investment Group Inc
NASDAQ:DHIL
USA $83.97 Million
First Business Financial Services
NASDAQ:FBIZ
USA $3.94 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Apex Healthcare Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Apex Healthcare Bhd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.35 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.28 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.22 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Apex Healthcare Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Apex Healthcare Bhd (2012–2024)

The table below shows the annual total liabilities of Apex Healthcare Bhd from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 RM219.27 Million
≈ $55.05 Million
+7.30%
2023-12-31 RM204.34 Million
≈ $51.30 Million
+9.37%
2022-12-31 RM186.83 Million
≈ $46.91 Million
+7.82%
2021-12-31 RM173.29 Million
≈ $43.51 Million
+13.30%
2020-12-31 RM152.95 Million
≈ $38.40 Million
-2.97%
2019-12-31 RM157.64 Million
≈ $39.58 Million
+2.38%
2018-12-31 RM153.97 Million
≈ $38.66 Million
+35.46%
2017-12-31 RM113.67 Million
≈ $28.54 Million
+6.80%
2016-12-31 RM106.44 Million
≈ $26.72 Million
+4.35%
2015-12-31 RM102.00 Million
≈ $25.61 Million
+8.51%
2014-12-31 RM94.00 Million
≈ $23.60 Million
+20.51%
2013-12-31 RM78.00 Million
≈ $19.58 Million
+5.41%
2012-12-31 RM74.00 Million
≈ $18.58 Million
--

About Apex Healthcare Bhd

KLSE:7090 Malaysia Medical Distribution
Market Cap
$473.43 Million
RM1.89 Billion MYR
Market Cap Rank
#12848 Global
#136 in Malaysia
Share Price
RM2.61
Change (1 day)
+0.00%
52-Week Range
RM2.11 - RM2.64
All Time High
RM3.34
About

Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, ant… Read more